Investors

Contacts

Codexis, Inc.
ir@codexis.com
You may automatically receive Codexis, Inc. investor information by e-mail. To choose your options for e-mail notification, please enter your e-mail address below and click Submit. The next page will display a menu of options.



To change your e-mail options at any time, re-enter your e-mail address and click Submit, then adjust your form entries.

Enter your e-mail address here:
Transfer Agent Contact
Wells Fargo Shareowner Services
1110 Centre Pointe Curve, Suite 101
Mendota Heights, MN 55120-4100
(800) 468-9716

www.wellsfargo.com/com/shareowner_services



Investor Relations Contact
Codexis, Inc.
200 Penobscot Drive
Redwood City, CA 94063
Phone: 650-421-8331
Email: ir@codexis.com



Request Additional Information
To receive alerts when this website is updated, please sign up for email alerts. To obtain additional information, please click here


Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS |

Share Page

X
| E-mail Alerts E-mail Alerts | IR Contacts Contacts | Financial Tear Sheet Tear Sheet

WE ARE BIOCATALYSISTM

We are an industrial biotechnology company delivering real business results through biobased innovation in chemicals, fuels, pharmaceuticals, consumer, and industrial products.

PHARMACEUTICAL ENZYMES


Supporting faster, cleaner, more efficient pharmaceutical manufacturing processes

Codexis delivers a range of chemicals at kilogram to multi-ton scale, through a partnered manufacturing network

CODEXIS

WHAT WE DO


Codexis delivers revolutionary biocatalytic routes that no one else can


CODEXIS

MEDIA CENTER


Visit our Media Center for the latest product information, videos, imagery, technical papers and press information.


CAREERS AT CODEXIS

An opportunity to make a difference.

Continued success at Codexis depends on the innovation, collaboration and commitment of people who are passionate about what they do


CODEXIS

INVESTOR CENTER


Access to Codexis information
for the investment community

built@zoomedia
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue